An expanding portfolio of next generation sequencing (NGS) panels and library preparation products for the accurate detection of genetic variants.
A broad range of array products for cytogenetics, rare disease, cancer and reproductive health research.
26 February 2019
OGT to open new Cytocell facility in Cambridge, UK
Sysmex demonstrates confidence and investment in OGT and the United Kingdom
30 January 2019
FDA grants de novo designation for OGT’s AML/MDS FISH probes
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden